The Use of “NATURAL” in Food Labeling: FDA’s Request for Comments Developing Your Position.

Slides:



Advertisements
Similar presentations
Agency Drafts Statement of Scope Governor Approves (2) No Agency Drafts: Special Report for rules impacting housing Fiscal Estimate.
Advertisements

1 New Changes to Medigap States Need to Adopt the Amended NAIC Medicare Supplement Model before July 1, 2009 / September 24, 2009.
TM The HIPAA Privacy Rule: Safeguarding Health Information in Research and Public Health Practice Centers for Disease Control and Prevention Beverly A.
1 Licensing in the Energy Sector Georgian National Energy And Water Supply Regulation Commission Nugzar Beridze June 27 – July 3, 2008.
What options do states have? What is Georgia planning to do? What are some of the other states doing? What are the possible implications to permit fees?
FDA’s Policy for Evaluating Bioengineered Foods Jeanette Glover Glew Food and Drug Administration Center For Food Safety and Applied Nutrition September,
GENETICALLY MODIFIED ORGANISM PRESENTATION 13 September 2013 By Department of Trade and Industry.
1 Overview of National Environmental Policy Act (NEPA)  Objective: Clarify the roles of NEPA and Negotiated Rulemaking Clarify the roles of NEPA and Negotiated.
Agency Drafts Statement of Scope Governor Approves Statement of Scope (2) No Agency Drafts: Special Report for rules impacting housing
Patient Protection and Affordable Care Act March 23, 2010.
Chapter 17 Food Safety. Copyright 2010, John Wiley & Sons, Inc. Food Safety Talk Foodborne illness: any illness that is related to the consumption of.
Introduction to GMOs: Myths and realities Masami Takeuchi, Ph.D. Food Safety Officer.
United States Department of Agriculture Food Safety and Inspection Service Public Meeting on Product Labeling: Definition of the Voluntary Claim “Natural”
Planning and Community Development Department Housing Element City Council February 03, 2014.
Implementing the Regulatory Flexibility Act. 2 Background The Regulatory Flexibility Act (5 U.S.C. 601–612) requires Federal agencies to— –Consider the.
Water Legislation Impacts on First Nations March 10, 2010 Hilton Hotel & Suites, Niagara Falls, Ontario Ontario First Nations Technical Services Corporation.
Preventive Controls for Human Food S upplemental Proposal 1
Proposed Gluten Regulations in Argentina Excipient Realities and Global Requirements.
The Modernization Commission's Approach To Illinois Brick and Indirect Purchaser Litigation Conference on International Cartels September 8, 2006 Jonathan.
GMOs – A Quiz By Kelly Johnston Vice President – Government Affairs Kelly Johnston.
1 Exceptional Events Rulemaking Proposal General Overview March 1, 2006 US EPA.
Biotechnology. D Biotechnology2 Definition Techniques used to modify deoxyribonucleic acid (DNA) or the genetic material of a microorganism, plant,
By Michelle Hoang Period 2 APES April 30, 2012 The Toxic Substances Control Act of 1976.
Investigational Devices and Humanitarian Use Devices June 2007.
Genetically Modified Foods Beth Roberson November 19, 2004 FST 490.
Food Label Claims and Terms Fall “Free” Less than 1/2 (0.5) gram of fat in a serving.
P.R.I.M.E. Finance Panel of Recognized International Market Experts in Finance Expert Input in US Regulatory Rulemaking Presentation by Dr. Sharon Brown-Hruska.
Federal Rulemaking Primer January 29, 2016 First Published: April 24, 2013 Producer: Alexander Perry Director: Afzal Bari.
DEPARTMENT OF HEALTH CENTER FOR BIOLOGICS AND HUMAN SERVICESEVALUATION and RESEARCH AND HUMAN SERVICES EVALUATION and RESEARCH Update on OCTGT Guidance.
Kansas City Power & Light and KCP&L Greater Missouri Operations – Suggestions for Chapter 22 Revisions Missouri Public Service Commission Meeting Aug 31,
BOARD MEETING Lethbridge School District No. 51 POLICY SEXUAL ORIENTATION, GENDER IDENTITY AND GENDER EXPRESSION.
Edible insects and missing legislation: the EU outlook 1. ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE, Legnaro (PD), ITALY
Department of Energy Energy Agency Reorganization Plan Little Hoover Commission Hearing on Governor Schwarzenegger’s Plan to Establish a Department of.
Climate: ANPR, SIPs and Section 821 WESTAR October 2, 2008.
When It’s a Matter of Law: “Friend of the Court” Briefs in Tobacco Litigation Kerry Cork, Staff Attorney Tobacco Control Legal Consortium.
1 Package on food improvement agents Food additives Food enzymes Flavourings Common procedure Developments since earlier consultation.
12 Angry Men v. The Agency: Why Preemption Should Resolve This Conflict in Drug Labeling Litigation Michelle L. Richards Asst. Professor – Applied Legal.
What is a sin tax? What is its purpose and function as a government restriction on the use of individual property? A sin tax is a relatively high tax.
Stages of Research and Development
Addressing the Federal Legalization of Cannabis Briefing to Standing Committee on Priorities and Planning June 7, 2017.
It Matters What We Say: Nutritional Claims on Product Packaging
FDA's Two New Draft Guidance on Software and Device
Food Additives Project
13 September 2013 By Department of Trade and Industry
GREEN MARKETING Efforts by: Karan Arora.
Recommended Draft Policy ARIN
How A Bill Becomes A Law.
Building the Defense of a Product: Taking a Technical Approach
Rules and Regulations GOVT 2305, Module 14.
Addressing the Federal Legalization of Cannabis Briefing to Standing Committee on Priorities and Planning June 7, 2017.
Premarket Notification 510(k) process
CHAPTER 22 Warranties and Product Liability.
Office of Legal Affairs
Final Rulemaking Nonattainment Source Review 25 Pa. Code, Chapter 121
Hot Topics in Food Labeling and Safety
Chapter 19 Pricing Strategies.
Kristin Leighty, Government Affairs Coordinator, NAHU
Michigan State University College of Law
A Managers Guide to Parental Leave
EMC – Air Quality Committee March 9, 2016
Essentials of the legal environment today, 5e
15A NCAC 2D Start-up, Shut-down, Malfunction SSM SIP Call
Module: GMO Presentation -Provides an update on current GMO messaging (consistent with GMOAnswers) and issues -Audiences: Members, industry allies and.
Exceptional Events Rulemaking Proposal
2017 AFL-CIO LCC Union Lawyers Conference
The Plant World and Genetic Engineering
Title I and Wagner-Peyser Act Waiver Requirements and Request Process
SIA in US Legislative Update Shanghai, China
Pennsylvania NewsMedia Association March 21, 2017
Regulatory Perspective of the Use of EHRs in RCTs
Presentation transcript:

The Use of “NATURAL” in Food Labeling: FDA’s Request for Comments Developing Your Position

“Common sense is not so common” -Voltaire

1.Review FDA request for comments regarding “natural.” 2.Review the FDA current position, regulatory filings, propose legislation and recent court rulings. 3.Determine how regulation of “natural” may affect your business; and 4.Suggest the steps to take in developing your position.

FDA poses numerous questions in an effort to cover the subject comprehensively. FDA used a number of questions addressing:  Food types  Food ingredients  Food processes  Food production practices, including genetic engineering  Consumer perceptions NOTE: FDA expressly advises that after receiving comments they may choose to take no further action.

Prior to 1993, the FDA chose not to establish any general rules concerning the use of “natural”. Since 1993, “natural” on food labeling means that: “nothing artificial or synthetic (including all color additives regardless of source) has been included in, or has been added to, a food that would normally be expected to be in the food.”

Current policy does not directly address:  Food production  Food processing  Genetic modification  Nutritional or health benefits

1. Recent class actions litigation. 2. Proposed legislation. 3. Citizen Petitions filed with the FDA.

 Cases involve “natural” claims involve allegation of the use of GMO’s synthetic/artificial ingredient, undisclosed “processes” and implied health attributes.  Some observations from the litigation:  Many cases involving GMO’s have been deferred pending FDA action.  There has been some success by plaintiff where an “artificial” or “synthetic” ingredient is found even in very small quantities.  Defendants are losing most requests for “federal” pre-emption of state law claims due to FDA’s limited position on “natural”.  Defendants are beginning to achieve some success in questioning the “class action certification” and the ability of the plaintiff to quantify the damage. (Did the consumer reasonably rely on the use of “natural” to a make a purchase decision and if so to what degree.)

 Many users of “natural” are taking corrective action to clarify their labels, modify their ingredients or discontinue the use of the term.  Nonetheless there are hundreds of products that have substantial use (and investment) of the term on processed products. Our review of registered trademarks indicated over 600 trademark filings. There are likely thousands of food products still using the term in some way.  Use of GMO’s or artificial or “synthetic” ingredients are likely to continue to draw attention of class action lawyers where “natural” is used on the label.  Very few cases have indicated significant exposure simply with regard to degree of processing.

Safe and Affordable Food Labeling Action (H.R. 1599)  Would require FDA to promulgate rules regarding the distribution and labeling of GMO products.  Removes state’s authority to regulate the matter; also require FDA promulgate a definition of “natural” final regulation within 30 months of passage.  Passed the House in July 2015 – government track gives its 27% change of passage.  Senate version does not require “natural” regulations. Earlier legislative attempts would require labeling of GMOs and prohibit the use of the term “natural” on any product containing GMOs. (These earlier Bills have not been moved in over a year).

 GMA  Sara Lee  The Sugar Association  Consumer Reports

 FDA should revise current policy on “natural” to authorize use of “natural,” on the label of foods that contain GMO technology.  Genes added to foods are not ingredients, and are neither artificial nor synthetic.  Biotech does not affect the objective attributes of the food derived from that plant.  FDA action could prevent patchwork of state rules directly at odds with FDA’s science-based policies on biotech foods.

SARA LEE RECOMMENDATION  FDA and FSIS should devise a unified, flexible policy governing use of “natural “to describe a good or food ingredient that does not contain any artificial flavor or flavoring, coloring ingredient (regardless of source) or any artificial or synthetic ingredient not normally expected in the product.  The degree of processing needed to produce the food or food ingredient should be considered in determining consumer expectation.  Case-by-case consideration of “natural” claims should be permitted under this flexible policy.

 FDA should define “natural” based on FSIS’s two-factor definition found in the Food Standards and Labeling Policy Book.  Product does not contain any artificial flavor or flavoring, coloring ingredient, chemical preservative or any other artificial or synthetic ingredient, and  The product and its ingredients are only minimally processed. *Traditional processes used to make food edible, or to preserve it, or to make it safe for human consumption, or physical processes that don’t fundamentally alter the product, and/or which only separate a whole food into component parts.

 FDA should prohibit use of “natural” on all food labels. I call these folks “Settlers”. They want to define “natural” to mean foods as they existed in the 1800’s. CONSUMER REPORTS RECOMMENDATIONS

How does “natural” impact your Association? 1)Are you currently marketing a product utilizing “natural”? 2)Do you sell significant product to others that rely on your product being “natural”? 3)How are your competitors (direct or substitute) affected? 4)How important is using “natural” to you or your competitors? 5)Are GMO’s used in your industry or are they foreseeable in your industry?

ACTION STEPS Convene a working group of your key staff (marketing, legal, quality control and other departments):  Review your current labels and those of your competitors.  Assess impacts of “natural” on you and your competitors.  Identify expert resources to help.  Monitor FDA submissions, court rulings and legislation.  Develop a compelling response/position.

DEVELOPING YOUR POSITION 1)How might the positions proposed in each citizen petition affect you currently and in the foreseeable future? 2)Do any of the current points of view fit your needs or do you need to create your own? 3)Of the questions posed by the FDA, which are most critical to your strategic business objectives? 4)Who in your industry or others are likely to share your position? Should you ally? 5)Consider if you need “focus groups” or consumer input? 6)Develop an action plan to make your position known. CURRENT FDA COMMENT DEADLINE IS MAY 10, 2016

Presented by Peter G. Latham, General Counsel Citrus World, Inc. c/o Latham, Shuker, Eden & Beaudine, LLP 111 N. Magnolia Avenue, Suite 1400 Orlando, Florida